Holen Sie sich die Stockscreener-App
0.715
0.21%
0.0015
Schlusskurs vom Vortag:
$0.7135
Offen:
$0.72
24-Stunden-Volumen:
21,290
Relative Volume:
0.00
Marktkapitalisierung:
$68.69M
Einnahmen:
$110.97M
Nettoeinkommen (Verlust:
$-33.18M
KGV:
-1.0876
EPS:
-0.6574
Netto-Cashflow:
$-11.80M
1W Leistung:
+0.70%
1M Leistung:
+55.10%
6M Leistung:
-78.85%
1J Leistung:
-79.80%
1-Tages-Spanne:
$0.701
$0.726
1-Wochen-Bereich:
$0.70
$0.75
52-Wochen-Spanne:
$0.40
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Firmenname
Mdxhealth Sa
Sektor
Branche
Telefon
-
Adresse
-
Compare MDXH vs TMO, DHR, NTRA, IQV, IDXX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
0.7199 | 68.08M | 110.97M | -33.18M | -11.80M | -0.6574 |
TMO
Thermo Fisher Scientific Inc
|
603.14 | 222.97B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.21 | 144.27B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
324.81 | 46.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
256.66 | 42.67B | 16.63B | 1.39B | 2.12B | 8.0674 |
IDXX
Idexx Laboratories Inc
|
518.88 | 40.98B | 4.45B | 1.10B | 1.06B | 13.59 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-31 | Eingeleitet | Lake Street | Buy |
| 2023-05-31 | Eingeleitet | TD Cowen | Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
MDxHealth Files 2026 Interim Report as Losses Deepen but Fresh Capital Extends Runway - TipRanks
MDxHealth (MDXH) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Execution - finance.yahoo.com
MDxHealth (Nasdaq: MDXH) faces going-concern doubts after interim loss - Stock Titan
MDxHealth (MDXH) Holds Steady Near $0.72 as Consolidation Persists Between Key LevelsLarge Cap Trends - dars.gov.et
MDxHealth stock extends strong August rally after beating Q2 revenue expectations - AD HOC NEWS
MDxHealth SAADR Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
MDxHealth’s Revenue Growth Is Real, but the Margin Story Still Needs Work - AlphaStreet
MDxHealth (MDXH) Momentum: Finishes 3.19% Up at $0.74 for the Current Session; Chart Watch - vinanet.vn
MDXH Maintained by BTIG -- Price Target Lowered to $2.00 - GuruFocus
MDxHealth price target lowered to $2 from $4 at BTIG - TipRanks
BTIG cuts MDxHealth stock price target on higher share count - Investing.com
MDxHealth SA (MDXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MDxHealth revenue up 16% in Q2, stock surges on guidance affirmation - scanx.trade
MDxHealth (MDXH) Q2 2026 Earnings Call Transcript - The Globe and Mail
MDxHealth (MDXH) Chart: Records a 5.15% Decrease to $0.72; Key Range: the Current Price Sits Inside the Supplied Technical Range on the DayFibonacci Extension - dars.gov.et
MDxHealth (MDXH) Earnings Reading: Reported EPS Tops Expectations for the Current Session; Share Move - vinanet.vn
MDxHealth (MDXH) Earnings Update: EPS Prints Above Forecast in Latest Trading; Post-Report: The Stock Ends Down 12.20% in the Available RecordTech Earnings Analysis - dars.gov.et
MDxHealth (MDXH) investors reveal 19.5% and 12.1% stakes - Stock Titan
MDxHealth (MDXH) Surges 4.58% to $0.84, Approaching Key Resistance at $0.88Cumulative Volume - vinanet.vn
MDxHealth (MDXH) Surges 74.89% to $0.81 as Momentum Builds in Diagnostic OncologyTime Weighted Price - vinanet.vn
MDxHealth (MDXH) Skyrockets 74.9% to $0.81: Key Levels to Watch After Explosive MoveLast Point Resistance - vinanet.vn
MDxHealth price target lowered to $3 from $5 at Lake Street - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA' - Sahm
MDxHealth (MDXH) Q2 2026 Earnings Call: Umsatz erholt sich, Prognose bestätigt - TradingKey
Mdxhealth S.A. Earnings Call Shows Growth, Strain - TipRanks
MDXH Maintained by Lake Street -- Price Target Lowered to $3.00 - GuruFocus
Bleichroeder LP Discloses Investment at MDxHealth SA with 33.2% Stake - TradingView
MDxHealth SA Stock 12‑Month Price Target Cut to $2.2, Implies 376% Upside - TradingView
Bleichroeder (MDXH) reports 31.6M-share, 33.2% holding in MDxHealth - Stock Titan
MDxHealth SA Stock 12‑Month Price Target Cut to $2.6, Implies 463% Upside - TradingView
MDxHealth S.A. Q2 2026 Earnings Call Summary - Yahoo Finance
Conferencia de resultados del T2 de 2026 de MDxHealth (MDXH): los ingresos se recuperan, se mantienen las previsiones - TradingKey
MDxHealth (MDXH) Q2 2026 Earnings Call: Revenue Rebounds, Guidance Maintained - TradingKey
MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record S - GuruFocus
MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record Sequential Growth and Strategic ... - finance.yahoo.com
Earnings call transcript: MDxHealth tops revenue estimates in Q2 2026 By Investing.com - Investing.com Canada
MDXH Looks 79.0% Undervalued on GF Value™ but Faces Value Trap W - GuruFocus
Earnings call transcript: MDxHealth tops revenue estimates in Q2 2026 - Investing.com
MDxHealth SA (MDXH) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Full Transcript: MDxHealth Q2 2026 Earnings Call - Benzinga
MDxHealth SA reports results for the quarter ended June 30Earnings Summary - TradingView
MDxHealth Raises $20 Million in Direct Share Offering and Amends Articles After Capital Increase - TipRanks
MDxHealth Posts Q2 2026 Revenue Growth, Exits Resolve Business and Raises $20 Million - TipRanks
MDxHealth ADR earnings missed, revenue topped estimates - Investing.com
MDXHEALTH SA ($MDXH) Releases Q2 2026 Earnings - Quiver Quantitative
Mdxhealth Reports Second Quarter 2026 Financial Results - The Manila Times
MDxHealth (MDXH) sells 44M shares, lifting total stock to 95.4M - Stock Titan
MDxHealth (NASDAQ: MDXH) lifts Q2 2026 revenue 16% but posts deeper loss - Stock Titan
Mdxhealth Sells 44M Shares for $20M Gross as Q2 Net Loss Hits $9.5M - Stock Titan
MDxHealth (MDXH) investor Laurence Lytton discloses 9.6% beneficial ownership - Stock Titan
Finanzdaten der Mdxhealth Sa-Aktie (MDXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.07%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):